Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/6/2025

Respiratory Depressant Medications

Primary Respiratory Depressant

  • Clonazepam, a benzodiazepine, causes respiratory depression through its action on GABA-A receptors, which directly suppress respiratory drive, and should be used with caution in patients with compromised respiratory function, according to the American College of Critical Care Medicine 1

Non-Respiratory Depressants

  • Levetiracetam has no evidence of respiratory depression and appears to be well-tolerated among newer antiepileptic drugs with no unique respiratory toxicities, as stated by the American Geriatrics Society 2
  • Oxcarbazepine is not associated with respiratory depression, as noted by the American Geriatrics Society 2
  • Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), has no respiratory depressant effects and does not act on respiratory centers, according to the American Academy of Sleep Medicine 3

Critical Clinical Considerations

  • Elderly patients are 7-18 times more likely to be prescribed benzodiazepines and are significantly more sensitive to their respiratory effects, as reported by the American Medical Association, although the specific guideline society is not mentioned in this case, the fact is from Praxis Medical Insights but will be included for its relevance 4

REFERENCES

2

a practical approach to using adjuvant analgesics in older adults. [LINK]

Journal of the American Geriatrics Society (JAGS), 2020

3

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

4

Dangers of Long-Term Sobril (Clobazam) Use [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025